Short answer
Axsome Therapeutics, Inc. (AXSM) filed an 8-K current report with the SEC on June 9, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 85.10% participation, with 43,777,536 of 51,439,952 eligible shares represented.
Axsome Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 85.10% participation, with 43,777,536 of 51,439,952 eligible shares represented
- Mark Saad and Susan Mahony re-elected as Class II directors through 2029
- Deloitte & Touche LLP appointment ratified for fiscal 2026, with 43,278,147 votes in favor
- Executive compensation approved on an advisory basis, with 37,818,384 votes in favor
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Axsome Therapeutics, Inc. 8-K filings
Get the next AXSM 8-K as it lands
Follow AXSM for push alerts, or ask the research agent what this filing means.